Literature DB >> 34471298

An evaluation of the in vitro antioxidant and antidiabetic potentials of camel and donkey milk peptides released from casein and whey proteins.

Ecem Akan1.   

Abstract

In this study, some biological activities including antioxidant activity (DPPH radical scavenging activity, ABTS radical scavenging activity, and CUPRAC assay), DPP-IV enzyme inhibitory activity, and α-glucosidase enzyme inhibitory activity of peptides released from in vitro gastrointestinal digested casein and the whey proteins of camel and donkey milk were evaluated. While the highest antioxidant activity was determined to be in the digested camel casein fraction using the ABTS and CUPRAC methods, the digested donkey casein fraction was determined to have the highest radical scavenging activity using the DPPH method. The highest DPP-IV inhibitory activity was detected in digested camel and donkey milk casein fractions. Digested whey fractions of camel and donkey milk had a lower DPP-IV inhibitory activity compared to the digested casein fractions. However, digested whey fractions of camel and donkey milk did not show α-glucosidase inhibitory activity, and digested donkey casein fraction showed the highest α-glucosidase inhibitory activity with a 12.5 µg/mL IC50 value. It was concluded that peptides released from digested casein fraction of camel and donkey milk have potent antioxidant and particularly antidiabetic properties. © Association of Food Scientists & Technologists (India) 2020.

Entities:  

Keywords:  Antioxidant activity; Bioactive peptides; Camel milk; DPP-IV inhibitory activity; Donkey milk; α-glucosidase inhibitory activity

Year:  2020        PMID: 34471298      PMCID: PMC8357899          DOI: 10.1007/s13197-020-04832-5

Source DB:  PubMed          Journal:  J Food Sci Technol        ISSN: 0022-1155            Impact factor:   3.117


  21 in total

1.  Antioxidant activity applying an improved ABTS radical cation decolorization assay.

Authors:  R Re; N Pellegrini; A Proteggente; A Pannala; M Yang; C Rice-Evans
Journal:  Free Radic Biol Med       Date:  1999-05       Impact factor: 7.376

2.  Identification of novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides in camel milk protein hydrolysates.

Authors:  Alice B Nongonierma; Sara Paolella; Priti Mudgil; Sajid Maqsood; Richard J FitzGerald
Journal:  Food Chem       Date:  2017-10-10       Impact factor: 7.514

3.  Biological activity of camel milk casein following enzymatic digestion.

Authors:  Maryam Salami; Ali Akbar Moosavi-Movahedi; Faezeh Moosavi-Movahedi; Mohammad Reza Ehsani; Reza Yousefi; Mohammad Farhadi; Amir Niasari-Naslaji; Ali Akbar Saboury; Jean-Marc Chobert; Thomas Haertlé
Journal:  J Dairy Res       Date:  2011-09-13       Impact factor: 1.904

4.  Inhibition of dipeptidyl peptidase (DPP)-IV and α-glucosidase activities by pepsin-treated whey proteins.

Authors:  Isabelle M E Lacroix; Eunice C Y Li-Chan
Journal:  J Agric Food Chem       Date:  2013-07-30       Impact factor: 5.279

5.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

Authors:  N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda
Journal:  Diabetes Res Clin Pract       Date:  2018-02-26       Impact factor: 5.602

6.  Dipeptidyl peptidase IV (DPP-IV) inhibitory properties of a camel whey protein enriched hydrolysate preparation.

Authors:  Alice B Nongonierma; Cloé Cadamuro; Aurélien Le Gouic; Priti Mudgil; Sajid Maqsood; Richard J FitzGerald
Journal:  Food Chem       Date:  2018-12-05       Impact factor: 7.514

7.  Slow and fast dietary proteins differently modulate postprandial protein accretion.

Authors:  Y Boirie; M Dangin; P Gachon; M P Vasson; J L Maubois; B Beaufrère
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.

Authors:  A Quirós; B Hernández-Ledesma; M Ramos; L Amigo; I Recio
Journal:  J Dairy Sci       Date:  2005-10       Impact factor: 4.034

Review 9.  Type 2 diabetes--therapy with dipeptidyl peptidase IV inhibitors.

Authors:  Hans-Ulrich Demuth; Christopher H S McIntosh; Raymond A Pederson
Journal:  Biochim Biophys Acta       Date:  2005-08-01

10.  Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.

Authors:  Kavitha Bharatham; Nagakumar Bharatham; Ki Hun Park; Keun Woo Lee
Journal:  J Mol Graph Model       Date:  2007-11-17       Impact factor: 2.518

View more
  4 in total

1.  Estimation of bioactive peptide content of milk from different species using an in silico method.

Authors:  Karim Parastouei; Masoumeh Jabbari; Fardin Javanmardi; Meisam Barati; Yaser Mahmoudi; Sajad Khalili-Moghadam; Houssein Ahmadi; Sayed Hossein Davoodi; Amin Mousavi Khaneghah
Journal:  Amino Acids       Date:  2022-03-19       Impact factor: 3.520

2.  Improvement of functional properties of cow's milk peptides through partial proteins hydrolysis.

Authors:  Thais S Milessi; Laiane A Lopes; Paula K Novelli; Paulo W Tardioli; Raquel L C Giordano
Journal:  J Food Sci Technol       Date:  2022-06-24       Impact factor: 3.117

3.  High-Resolution Mass Spectrometry and Chemometrics for the Detailed Characterization of Short Endogenous Peptides in Milk By-Products.

Authors:  Carmela Maria Montone; Sara Elsa Aita; Chiara Cavaliere; Andrea Cerrato; Aldo Laganà; Susy Piovesana; Anna Laura Capriotti
Journal:  Molecules       Date:  2021-10-27       Impact factor: 4.411

4.  Effect of Varying Dietary Crude Protein Level on Milk Production, Nutrient Digestibility, and Serum Metabolites by Lactating Donkeys.

Authors:  Yuanxi Yue; Li Li; Manman Tong; Shuyi Li; Yanli Zhao; Xiaoyu Guo; Yongmei Guo; Binlin Shi; Sumei Yan
Journal:  Animals (Basel)       Date:  2022-08-13       Impact factor: 3.231

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.